🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Bristol Myers Squibb 
Pharma / Pharma
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | Web1. Regulatory issues: Any changes in FDA regulations or other government intervention can significantly impact Bristol Myer Squibb's operations and profitability.
2. Competitive Dynamics: The biopharmaceutical industry is a highly competitive space, and Bristol Myers Squibb must constantly watch its competitors and stay ahead of the curve in order to stay competitive.
3. Research and Development Costs: With changes in the industry, Bristol Myers Squibb regularly invests in research and development in order to develop new products and treatments. This significant financial investment may not produce returns if the new product offerings are not successful in the market.
4. Legal Issues: Bristol Myers Squibb is subject to various legal and environmental issues as part of its operations. This could include patent disputes, fines, and lawsuits which could all negatively impact the company's profitability.
5. Macroeconomic Factors: Changes in economic conditions and changing consumer preferences can significantly impact Bristol Myers Squibb's business. If the company does not adapt, it could negatively affect the company's sales and profitability.
Wait! There's more — sign up for free or log in